Gelbert F, Enjolras O, Deffrenne D, Aymard A, Mounayer C, Merland J J
Department of Neuroradiology, Hôpital Lariboisière, Paris, France.
Neuroradiology. 2000 Sep;42(9):692-6. doi: 10.1007/s002340000364.
Labial venous malformations are relatively common. Depending on their size, they are responsible for functional and cosmetic handicap. When treatment is indicated, it will be based on percutaneous sclerotherapy, using Ethibloc or Aetoxysclerol, with surgery in some patients. Our purpose was to review 23 patients with soft-tissue venous malformations of the lips. Follow-up ranged from 6 months to 4 years. Sclerotherapy alone or with surgical resection achieved good results in 18 patients. In six patients mild improvement was obtained. No worsening of the initial clinical situation occurred, and no persistent complication was observed. We discuss the indications for treatment and the different types of sclerosing agent. Percutaneous sclerotherapy is safe and is effective for small and medium-size labial malformations. For larger lesions the treatment is more complex and combined long term sclerotherapy and surgery procedures may be required over several years.
唇部静脉畸形相对常见。根据其大小,会导致功能和美观方面的障碍。当需要治疗时,将基于经皮硬化治疗,使用乙碘油或十四烷基硫酸钠,部分患者还需手术治疗。我们的目的是回顾23例唇部软组织静脉畸形患者。随访时间为6个月至4年。单纯硬化治疗或联合手术切除在18例患者中取得了良好效果。6例患者有轻度改善。未出现初始临床状况恶化,也未观察到持续性并发症。我们讨论了治疗指征和不同类型的硬化剂。经皮硬化治疗对于中小型唇部畸形是安全且有效的。对于较大的病变,治疗更为复杂,可能需要数年的长期硬化治疗和手术联合程序。